Retraction
Arid3b Is Critical for B Lymphocyte Development
Paper Information
Record ID:
55971
Author(s):
Publication Date:
August 18, 2016
Retraction Date:
August 22, 2024
(1.2 year years ago)
Subjects:
Institutions:
- Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, United States of America
- Harper Cancer Research Institute, South Bend, Indiana, United States of America
- Institute for Cellular and Molecular Biology, Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas, United States of America
- Department of Microbiology and Immunology, Indiana University School of Medicine, South Bend, Indiana, United States of America
- Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, South Bend, Indiana, United States of America
- Deparment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, United States of America
Country:
🇺🇸 United StatesArticle Type:
Publisher:
PLoS
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1371/journal.pone.0309551Citations (11)
11
Total Citations2
Post-Retraction(18.2%)
8
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
1
Within 30 days
2
Within 1 year
0
After 2+ years
55
Days since retraction (latest)
Arid3c identifies an uncharacterized subpopulation of V2 interneurons during embryonic spinal cord development
Estelle Renaux, Christophe Baudouin, Olivier Schakman et al. (10 authors)
Frontiers in Cellular Neuroscience
Open Access
Published: Oct 2024
55 days after retraction
Correction: Retraction: Arid3b Is Critical for B Lymphocyte Development
Unknown Authors
PLoS ONE
Open Access
Published: Sep 2024
18 days after retraction
Retraction: Arid3b Is Critical for B Lymphocyte Development
Unknown Authors
PLoS ONE
Open Access
Published: Aug 2024
1 citation
1 citation
Same day as retraction
MicroRNAs and Corresponding Targets in Esophageal Cancer as Shown<i>In Vitro</i>and<i>In Vivo</i>in Preclinical Models
Ulrich H. Weidle, Adam Nopora
Cancer Genomics & Proteomics
Open Access
Published: Jan 2022
1 citation
1 citation
964 days before retraction
Identification of Tumor Microenvironment-Related Prognostic Biomarkers for Ovarian Serous Cancer 3-Year Mortality Using Targeted Maximum Likelihood Estimation: A TCGA Data Mining Study
Lu Wang, Xiaoru Sun, Chuandi Jin et al. (5 authors)
Frontiers in Genetics
Open Access
Published: Jun 2021
4 citations
4 citations
1176 days before retraction
ARID3A and ARID3B induce stem promoting pathways in ovarian cancer cells
Paige Dausinas, Kirthi Pulakanti, Sridhar Rao et al. (6 authors)
Gene
Open Access
Published: Feb 2020
21 citations
21 citations
1652 days before retraction
Impact of HVT Vaccination on Splenic miRNA Expression in Marek’s Disease Virus Infections
Julie A. Hicks, Hsiao‐Ching Liu
Genes
Open Access
Published: Feb 2019
8 citations
8 citations
2025 days before retraction
Understanding B Lymphocyte Development: A Long Way to Go
Malavika Bhattacharya
IntechOpen eBooks
Open Access
Published: Jan 2019
6 citations
6 citations
2045 days before retraction
RUNX1 and the endothelial origin of blood
Long Gao, Joanna Tober, Peng Gao et al. (6 authors)
Experimental Hematology
Open Access
Published: Oct 2018
84 citations
84 citations
2122 days before retraction
A response prediction model for taxane, cisplatin, and 5-fluorouracil chemotherapy in hypopharyngeal carcinoma
Qi Zhong, Jugao Fang, Zhigang Huang et al. (13 authors)
Scientific Reports
Open Access
Published: Aug 2018
17 citations
17 citations
2197 days before retraction
A Role for the Transcription Factor Arid3a in Mouse B2 Lymphocyte Expansion and Peritoneal B1a Generation
Katrin Habir, Shahin Aeinehband, Fredrik Wermeling et al. (4 authors)
Frontiers in Immunology
Open Access
Published: Oct 2017
10 citations
10 citations
2494 days before retraction
Quick Stats
Total Citations:
11
Years Since Retraction:
1.2 year
Open Access:
Yes
Last Checked:
Jul 24, 2025